Bristol-Myers Squibb (BMY) Tops Q2 EPS by 12c, Raises FY Guidance
Tweet Send to a Friend
Bristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $1.18, $0.12 better ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
